278 related articles for article (PubMed ID: 15732001)
1. Hepatitis C virus particles and lipoprotein metabolism.
André P; Perlemuter G; Budkowska A; Bréchot C; Lotteau V
Semin Liver Dis; 2005 Feb; 25(1):93-104. PubMed ID: 15732001
[TBL] [Abstract][Full Text] [Related]
2. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC
Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516
[TBL] [Abstract][Full Text] [Related]
3. Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection.
Yang Z; Wang X; Chi X; Zhao F; Guo J; Ma P; Zhong J; Niu J; Pan X; Long G
J Virol; 2016 Nov; 90(21):9632-9643. PubMed ID: 27535051
[TBL] [Abstract][Full Text] [Related]
4. Conformational changes accompanying self-assembly of the hepatitis C virus core protein.
Kunkel M; Watowich SJ
Virology; 2002 Mar; 294(2):239-45. PubMed ID: 12009865
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus core protein, lipid droplets and steatosis.
Roingeard P; Hourioux C
J Viral Hepat; 2008 Mar; 15(3):157-64. PubMed ID: 18086178
[TBL] [Abstract][Full Text] [Related]
6. High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients.
Scholtes C; Ramière C; Rainteau D; Perrin-Cocon L; Wolf C; Humbert L; Carreras M; Guironnet-Paquet A; Zoulim F; Bartenschlager R; Lotteau V; André P; Diaz O
Hepatology; 2012 Jul; 56(1):39-48. PubMed ID: 22290760
[TBL] [Abstract][Full Text] [Related]
7. Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies.
Blaising J; Pécheur EI
Biochimie; 2013 Jan; 95(1):96-102. PubMed ID: 22884392
[TBL] [Abstract][Full Text] [Related]
8. A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles.
Tao W; Xu C; Ding Q; Li R; Xiang Y; Chung J; Zhong J
Virology; 2009 Dec; 395(1):67-76. PubMed ID: 19793603
[TBL] [Abstract][Full Text] [Related]
9. Assembly of infectious hepatitis C virus particles.
Bartenschlager R; Penin F; Lohmann V; André P
Trends Microbiol; 2011 Feb; 19(2):95-103. PubMed ID: 21146993
[TBL] [Abstract][Full Text] [Related]
10. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles.
André P; Komurian-Pradel F; Deforges S; Perret M; Berland JL; Sodoyer M; Pol S; Bréchot C; Paranhos-Baccalà G; Lotteau V
J Virol; 2002 Jul; 76(14):6919-28. PubMed ID: 12072493
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins.
Mancone C; Steindler C; Santangelo L; Simonte G; Vlassi C; Longo MA; D'Offizi G; Di Giacomo C; Pucillo LP; Amicone L; Tripodi M; Alonzi T
Gut; 2011 Mar; 60(3):378-86. PubMed ID: 20940285
[TBL] [Abstract][Full Text] [Related]
12. How does hepatitis C virus enter cells?
Diedrich G
FEBS J; 2006 Sep; 273(17):3871-85. PubMed ID: 16934030
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis.
Perlemuter G; Sabile A; Letteron P; Vona G; Topilco A; Chrétien Y; Koike K; Pessayre D; Chapman J; Barba G; Bréchot C
FASEB J; 2002 Feb; 16(2):185-94. PubMed ID: 11818366
[TBL] [Abstract][Full Text] [Related]
14. Structural requirements for assembly and homotypic interactions of the hepatitis C virus core protein.
Kim M; Ha Y; Park HJ
Virus Res; 2006 Dec; 122(1-2):137-43. PubMed ID: 16949699
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.
Andréo U; Maillard P; Kalinina O; Walic M; Meurs E; Martinot M; Marcellin P; Budkowska A
Cell Microbiol; 2007 Oct; 9(10):2445-56. PubMed ID: 17517063
[TBL] [Abstract][Full Text] [Related]
16. Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein.
Sato S; Fukasawa M; Yamakawa Y; Natsume T; Suzuki T; Shoji I; Aizaki H; Miyamura T; Nishijima M
J Biochem; 2006 May; 139(5):921-30. PubMed ID: 16751600
[TBL] [Abstract][Full Text] [Related]
17. In vitro interaction between hepatitis C virus (HCV) envelope glycoprotein E2 and serum lipoproteins (LPs) results in enhanced cellular binding of both HCV E2 and LPs.
Wunschmann S; Muller HM; Stipp CS; Hemler ME; Stapleton JT
J Infect Dis; 2006 Oct; 194(8):1058-67. PubMed ID: 16991080
[TBL] [Abstract][Full Text] [Related]
18. Role of lipid metabolism in hepatitis C virus assembly and entry.
Popescu CI; Dubuisson J
Biol Cell; 2009 Oct; 102(1):63-74. PubMed ID: 19857204
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody.
Pumeechockchai W; Bevitt D; Agarwal K; Petropoulou T; Langer BC; Belohradsky B; Bassendine MF; Toms GL
J Med Virol; 2002 Nov; 68(3):335-42. PubMed ID: 12226819
[TBL] [Abstract][Full Text] [Related]
20. Correlation of serum HCV core concentration with blood level of lipid and antioxidants in various forms of liver diseases.
Irshad M; Dhar I; Gupta S; Khushboo ; Joshi YK
Hepatogastroenterology; 2007; 54(75):898-902. PubMed ID: 17591087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
